NCT06271304

Brief Summary

The study investigates whether add-on treatment with eyewear that blocks the short wavelengths of visible light (\<500nm) reduces manic symptoms and improves sleep in patients receiving outpatient treatment as usual for bipolar disorder. When in a hypomanic or manic phase, participants will be randomized to receive add-on treatment with either blue blocking or low filtration eyewear from 18 PM to 8 AM daily for 7 days. After this initial intervention phase, the eyewear is used daily for 3 months in either antimanic dose (14 hours) or maintenance dose (2 hours before bedtime).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Apr 2024Jun 2026

First Submitted

Initial submission to the registry

February 14, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 21, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

April 5, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

May 8, 2024

Status Verified

May 1, 2024

Enrollment Period

1.9 years

First QC Date

February 14, 2024

Last Update Submit

May 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Manic symptoms

    Change in Young Mania Rating Scale Score, range 0-60, higher scores indicating greater manic symptom load

    7 days

Secondary Outcomes (5)

  • Mood instability

    15 weeks

  • Objective sleep quality

    7 days

  • Objective sleep quality

    15 weeks

  • Subjective sleep quality

    7 days

  • Subjective sleep quality

    15 weeks

Study Arms (2)

Blue blocking glasses (BB)

EXPERIMENTAL

Eyewear with orange-tinted lenses that block 99% of short wavelength visible light \< 500 nm

Device: Blue blocking eyewear

Low filtration glasses (LF)

SHAM COMPARATOR

Eyewear with clear lenses that block 15% of short wavelength light \< 500 nm

Device: Low filtration eyewear

Interventions

Eyewear is worn daily from 6 PM to 8 AM during manic/hypomanic state Eyewear is worn daily 2 hours before planned bedtime during euthymic, depressive and mixed state

Blue blocking glasses (BB)

Eyewear is worn daily from 6 PM to 8 AM during manic/hypomanic state Eyewear is worn daily 2 hours before planned bedtime during euthymic, depressive and mixed state

Low filtration glasses (LF)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of bipolar disorder
  • YMRS-score \>13
  • Age 18-60 years
  • Speaks and writes Danish at a level equal to mother tongue

You may not qualify if:

  • Not willing or able to adhere to the protocol
  • Severe eye disorder or eye trauma
  • Treatment with betablockers
  • Sleep disturbances not related to BD (e.g, sleep apnea, restless legs syndrome) • • Substance abuse
  • Unwilling to use the electronic self-monitoring system, the Monsenso system
  • Prior/current use of BB glasses
  • Current/planned pregnancy
  • Night shift work
  • Suicidality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Psychiatric Center Copenhagen

Copenhagen, 2100, Denmark

RECRUITING

MeSH Terms

Conditions

Bipolar Disorder

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental Disorders

Study Officials

  • Lars Kessing

    Mental Health Center Copenhagen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants are instructed not to discuss the appearance of their designated eyewear with their care providers or the investigator or outcome assessor. Participants are not informed of the exact filtration level of their eyewear.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Outcome assessors will be blinded to the treatment assignment. At the beginning of each assessment, participants will be instructed not to describe or discuss their glasses with the assessor. Because the two types of glasses are of different color (clear (LF) and orange (BB)), we cannot guarantee a full blinding of the participants. Participants will be informed that we are studying the effects of two different types of light filters without more detail so they will not be provided with certain knowledge of which condition is expected to yield the largest effect. We will assess the integrity of the blind by asking participants whether they think they received glasses with high or low filtration lenses at the end of the study. Participants will be discouraged from actively seeking information about sleep glasses during the study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2024

First Posted

February 21, 2024

Study Start

April 5, 2024

Primary Completion

March 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

May 8, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations